FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2156818388> ?p ?o ?g. }

• W2156818388 endingPage "7" @default.
• W2156818388 startingPage "480" @default.
• W2156818388 abstract "Lymphokine activated killer (LAK) cells represent mixtures of natural killer (NK) and non-MHC-restricted CTLs that have the capacity to lyse a variety of tumor cells and MHC class I-negative target cells. Although it is clear that NK cells are negatively regulated by interactions with MHC class Ia or class Ib molecules, the regulation of LAK-derived T cells has not been clarified to date. In the studies presented here, we demonstrate that IFN-gamma treatment of tumor cells can induce their resistance to LAK-derived T cells in a manner similar to that seen for NK cells. The IFN-gamma-mediated suppression of LAK activity correlates with increased MHC class I expression by the tumor cells, and the inhibition of LAK-mediated cytotoxicity can be reversed in the presence of class I-specific antibody. Furthermore, the expression of MHC class Ia or class Ib molecules in class I-negative cell lines can reduce their susceptibility to LAK-mediated cytotoxicity. This principle of negative regulation by MHC class I molecules applies to LAK-derived T cells generated from peripheral blood lymphocytes of renal cell carcinoma patients and healthy, control donors. Although LAK-derived T cells can be inhibited in their lytic activity through interactions with MHC class Ia and class Ib molecules, they do not express the known inhibitory receptors specific for these ligands that are found on NK cells. Apparently, LAK-derived T cells are negatively regulated by as yet undefined inhibitory receptors." @default.
• W2156818388 created "2016-06-24" @default.
• W2156818388 creator A5009178208 @default.
• W2156818388 creator A5035882618 @default.
• W2156818388 creator A5080949843 @default.
• W2156818388 creator A5089500666 @default.
• W2156818388 date "2002-01-15" @default.
• W2156818388 modified "2023-09-23" @default.
• W2156818388 title "Retaliation against tumor cells showing aberrant HLA expression using lymphokine activated killer-derived T cells." @default.
• W2156818388 cites W1222874231 @default.
• W2156818388 cites W1516226356 @default.
• W2156818388 cites W158780073 @default.
• W2156818388 cites W1641011985 @default.
• W2156818388 cites W1887940719 @default.
• W2156818388 cites W1931140415 @default.
• W2156818388 cites W1950572133 @default.
• W2156818388 cites W1963907763 @default.
• W2156818388 cites W1966930760 @default.
• W2156818388 cites W1973369367 @default.
• W2156818388 cites W1976326147 @default.
• W2156818388 cites W1979014817 @default.
• W2156818388 cites W1985981664 @default.
• W2156818388 cites W1986656701 @default.
• W2156818388 cites W1991026061 @default.
• W2156818388 cites W1993191461 @default.
• W2156818388 cites W1999774568 @default.
• W2156818388 cites W2001640132 @default.
• W2156818388 cites W2007679709 @default.
• W2156818388 cites W2009027049 @default.
• W2156818388 cites W2018227907 @default.
• W2156818388 cites W2018238733 @default.
• W2156818388 cites W2023415042 @default.
• W2156818388 cites W2024769127 @default.
• W2156818388 cites W2030152116 @default.
• W2156818388 cites W2032336406 @default.
• W2156818388 cites W2033501724 @default.
• W2156818388 cites W2038545704 @default.
• W2156818388 cites W2049598511 @default.
• W2156818388 cites W2055603968 @default.
• W2156818388 cites W2059378562 @default.
• W2156818388 cites W2061672021 @default.
• W2156818388 cites W2062581776 @default.
• W2156818388 cites W2076161134 @default.
• W2156818388 cites W2080360382 @default.
• W2156818388 cites W2081906410 @default.
• W2156818388 cites W2085925464 @default.
• W2156818388 cites W2090786116 @default.
• W2156818388 cites W2097641815 @default.
• W2156818388 cites W2108639934 @default.
• W2156818388 cites W2114695617 @default.
• W2156818388 cites W2115511126 @default.
• W2156818388 cites W2116171543 @default.
• W2156818388 cites W2119666709 @default.
• W2156818388 cites W2130901389 @default.
• W2156818388 cites W2135808990 @default.
• W2156818388 cites W2143381422 @default.
• W2156818388 cites W2146335364 @default.
• W2156818388 cites W2159199533 @default.
• W2156818388 cites W2160579328 @default.
• W2156818388 cites W2161393087 @default.
• W2156818388 cites W2172180689 @default.
• W2156818388 cites W2244423751 @default.
• W2156818388 cites W2299723652 @default.
• W2156818388 cites W2327749578 @default.
• W2156818388 cites W2334218577 @default.
• W2156818388 cites W2399140547 @default.
• W2156818388 cites W2416355763 @default.
• W2156818388 cites W2430174839 @default.
• W2156818388 cites W360966800 @default.
• W2156818388 cites W577526784 @default.
• W2156818388 cites W2102277634 @default.
• W2156818388 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11809699" @default.
• W2156818388 hasPublicationYear "2002" @default.
• W2156818388 type Work @default.
• W2156818388 sameAs 2156818388 @default.
• W2156818388 citedByCount "6" @default.
• W2156818388 crossrefType "journal-article" @default.
• W2156818388 hasAuthorship W2156818388A5009178208 @default.
• W2156818388 hasAuthorship W2156818388A5035882618 @default.
• W2156818388 hasAuthorship W2156818388A5080949843 @default.
• W2156818388 hasAuthorship W2156818388A5089500666 @default.
• W2156818388 hasConcept C129374314 @default.
• W2156818388 hasConcept C139563560 @default.
• W2156818388 hasConcept C147483822 @default.
• W2156818388 hasConcept C149532602 @default.
• W2156818388 hasConcept C154317977 @default.
• W2156818388 hasConcept C167672396 @default.
• W2156818388 hasConcept C170627219 @default.
• W2156818388 hasConcept C202751555 @default.
• W2156818388 hasConcept C203014093 @default.
• W2156818388 hasConcept C206191192 @default.
• W2156818388 hasConcept C207936829 @default.
• W2156818388 hasConcept C2778102761 @default.
• W2156818388 hasConcept C28651165 @default.
• W2156818388 hasConcept C37386791 @default.
• W2156818388 hasConcept C49382859 @default.
• W2156818388 hasConcept C502942594 @default.
• W2156818388 hasConcept C55493867 @default.

• next